Large-scale testing (Phase 3)Study completedNCT01040052What this trial is testingAssess the Safety of Adacel® VaccineWho this might be right forDiphtheriaTetanusPertussis Sanofi Pasteur, a Sanofi Company 30
Early research (Phase 1)Study completedNCT02430506What this trial is testingEvaluate Safety and Immunogenicity of AERAS-402 Administered in HIV-negative, BCG-vaccinated, QFT (+) and (-) Adults Without Evidence of TBWho this might be right forTuberculosis Aeras 20
Post-approval studies (Phase 4)UnknownNCT01555047What this trial is testingCorrelation Among Sperm DNA Fragmentation, Genitourinary Infection by Mycoplasma in Male and the Pregnancy Outcomes After IUI in Their PartnerWho this might be right forMycoplasma Feng Pan 200
Post-approval studies (Phase 4)Study completedNCT01318356What this trial is testingThe Qure Study: Q-fever Fatigue Syndrome - Response to TreatmentWho this might be right forQ FeverFatigue Syndrome, ChronicCoxiella Infection Radboud University Medical Center 156
Post-approval studies (Phase 4)UnknownNCT02618057What this trial is testingEffects of Oral Steroid in Mycoplasma Pneumoniae PneumoniaWho this might be right forMycoplasma Pneumoniae Pneumonia Seoul National University Hospital 80
Large-scale testing (Phase 3)Study completedNCT00742469What this trial is testingRifaximin for Prevention of Travellers' DiarrheaWho this might be right forDiarrhea Bausch Health Americas, Inc. 210
Not applicableEnded earlyNCT05613322What this trial is testingResistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing BacteremiaWho this might be right forBacteremia Sepsis Resistell AG 246
Not applicableStudy completedNCT03931239What this trial is testingThe Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 WeeksWho this might be right forDiphtheriaTetanusPertussis+2 more Vabiotech 222
Large-scale testing (Phase 3)Study completedNCT01214837What this trial is testingSafety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of LifeWho this might be right forMeningococcal DiseaseMeningococcal Meningitis Novartis Vaccines 751
Large-scale testing (Phase 3)Looking for participantsNCT07204457What this trial is testingImmunogenicity and Safety of Meningococcal Conjugate Vaccine (EG-MCV4) in Healthy Adults Aged 19 to 55 Years OldWho this might be right forMeningococcal Infections EyeGene Inc. 1,123
Large-scale testing (Phase 3)Study completedNCT02477995What this trial is testingStudy of Adsorption Tetanus-diphtheria-acellular Pertussis (DTaP) Vaccine in Healthy 3 to 5 Months InfantsWho this might be right forPertussis Jiangsu Province Centers for Disease Control and Prevention 1,200
Not applicableStudy completedNCT07444502What this trial is testingSafety Monitoring of Boostagen® Vaccine in ThailandWho this might be right forPertussis (Whooping Cough)TetanusDiphtheria BioNet-Asia Co., Ltd. 10,727
Large-scale testing (Phase 3)UnknownNCT03491995What this trial is testingA Unique Regimen for Treatment of Helicobacter Pylori InfectionWho this might be right forHelicobacter Infections Sherief Abd-Elsalam 600
Not applicableUnknownNCT06286007What this trial is testingPrevalence and Impact of Pertussis and RSV on Asthma Severity and ControlWho this might be right forAsthmaPertussisRSV Infection Hospital Clinico Universitario de Santiago 784
Large-scale testing (Phase 3)Study completedNCT00944034What this trial is testingSafety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12Who this might be right forMeningococcal DiseaseMeningococcal Meningitis Novartis Vaccines 1,588
Post-approval studies (Phase 4)Study completedNCT01823536What this trial is testingPersistence of Immunogenicity of MenACWY Conjugate Vaccine 5 Years After Childhood Vaccination, and Immune Response to a Booster DoseWho this might be right forMeningococcal Disease Novartis Vaccines 465
Testing effectiveness (Phase 2)Study completedNCT05387083What this trial is testingA Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05Who this might be right forHealthy Volunteer Tarsus Pharmaceuticals, Inc. 30
Large-scale testing (Phase 3)Study completedNCT02100631What this trial is testingLive Oral Cholera Vaccine, PXVX200 in Healthy Older AdultsWho this might be right forCholera Bavarian Nordic 398
Early research (Phase 1)Study completedNCT00910351What this trial is testingCipro Inhaler for Cystic Fibrosis Children Ages 6-12Who this might be right forPseudomonas Infection Bayer 19
Not applicableUnknownNCT05562102What this trial is testingTyVECO: Surveillance ProtocolWho this might be right forTyphoid FeverIntestinal Perforation International Vaccine Institute 48,000